查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587818

血液筛检市场规模、份额、趋势分析报告：按技术、按产品、按地区、细分市场预测，2025-2030 年

Blood Screening Market Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

血液筛检市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球血液筛检市场规模预计将达到66.2亿美元，2025年至2030年复合年增长率为11.9%。

该市场的成长得益于捐赠者筛检的增加和市场参与企业不断进步的技术。由于捐血的增加、对输血感染疾病的认识的提高以及行业技术的发展，对血液筛检测试的需求持续增加。此外，各国政府要求对所有捐血的血液进行多种病毒检测。

需要对所有捐血的血液进行彻底筛检，以确保接受者获得最安全的血液製品。截至 2015 年，此类检测包括筛检红血球抗体和感染疾病病原体：HIV-1、HIV-2、肝炎病毒、西尼罗河病毒 (WNV)、人类 T 淋巴细胞病毒 (HTLV)、T. Cruzi，T. pallidum（梅毒）。捐血的一个条件是所有这些测试结果均为阴性。

技术的发展正在提高测试的灵敏度和效率。例如，2016 年，美国FDA核准了Hologic, Inc. 和 Grifols 的 Procleix兹卡病毒检测方法，用于筛检捐血的血液。此外，美国FDA 于 2013 年核准了下一代定序 (NGS) 技术。该技术比传统 DNA 分析方法更便宜、更快速。

血液筛检市场报告亮点

  • 核酸增幅检查（NAT）占据市场主导地位，2024 年占最大收益占有率，达 41.2%。这是因为HIV、肝炎等感染疾病的盛行率不断增加，需要NAAT提供的准确、快速的检测方法。
  • 次世代定序(NGS) 预计在预测期内复合年增长率为 16.5%。这项技术显着降低了定序成本，同时提高了准确性，彻底改变了基因组分析。
  • 试剂引领市场，2024 年占最大销售份额，达 73.4%。试剂是诊断测试的重要组成部分，提供引发特定反应以获得准确结果所需的化学、生物和免疫物质。
  • 由于技术进步和对有效诊断解决方案的需求不断增加，预计设备在预测期内将以 10.8% 的最快复合年增长率增长。
  • 北美血液筛检市场在全球市场占据主导地位，2024年收益占有率最大，为38.4%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章血液筛检市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章血液筛检市场：技术业务分析

  • 2024年及2030年技术市场占有率
  • 技术细分仪表板
  • 2018-2030 年按技术分類的市场规模、预测与趋势分析
  • 核酸增幅检查（NAT）
  • ELISA
  • 化学冷光免疫检测（CLIA & EIA）
  • 次世代定序（NGS）
  • 蛋白质印迹 (WB)

第五章血液筛检市场：产品业务分析

  • 2024年及2030年产品市场占有率
  • 产品细分仪表板
  • 2018-2030 年按产品分類的市场规模、预测与趋势分析
  • 试剂
  • 装置

第六章血液筛检市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争状况

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介
    • Abbott
    • Danaher Corporation（Beckman Coulter）
    • Becton Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Grifols, SA
    • Ortho-Clinical Diagnostics, Inc.
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific, Inc.
    • SOFINA sa（Biomerieux）
Product Code: GVR-1-68038-215-0

Blood Screening Market Growth & Trends:

The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.

Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Blood Screening Market Report Highlights:

  • Nucleic acid amplification tests (NAT) dominated the market and accounted for the largest revenue share of 41.2% in 2024 attributed to the increasing prevalence of infectious diseases, such as HIV and hepatitis, necessitating accurate and rapid testing methods that NAATs provide.
  • Next Generation Sequencing (NGS) is expected to grow at a CAGR of 16.5% over the forecast period. The technology has revolutionized genomic analysis by significantly reducing sequencing costs while improving accuracy.
  • Reagents led the market and accounted for the largest revenue share of 73.4% in 2024. Reagents are essential components in diagnostic tests, providing the necessary chemical, biological, or immunological substances to elicit specific reactions for accurate results.
  • Instruments are expected to grow at the fastest CAGR of 10.8% over the forecast period, owing to technological advancements and increasing demand for effective diagnostic solutions.
  • North America blood screening market dominated the global market and accounted for the largest revenue share of 38.4% in 2024 attributed to advanced healthcare infrastructure and a strong emphasis on patient safety.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Blood Screening Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Nucleic Acid Amplification Test (NAT)
    • 4.4.1. Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • 4.5. ELISA
    • 4.5.1. ELISA Market, 2018 - 2030 (USD Million)
  • 4.6. Chemiluminescence Immunoassay (CLIA & EIA )
    • 4.6.1. Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • 4.7. Next Generation Sequencing (NGS)
    • 4.7.1. Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • 4.8. Western Blotting (WB)
    • 4.8.1. Western Blotting (WB) Market, 2018 - 2030 (USD Million)

Chapter 5. Blood Screening Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Reagent
    • 5.4.1. Reagent Market, 2018 - 2030 (USD Million)
  • 5.5. Instrument
    • 5.5.1. Instrument Market, 2018 - 2030 (USD Million)

Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Danaher Corporation (Beckman Coulter)
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Becton Dickinson and Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hoffman-La Roche Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Grifols, S.A.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Ortho-Clinical Diagnostics, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Siemens Healthcare GmbH
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Thermo Fisher Scientific, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. SOFINA s.a (Biomerieux)
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Blood Screening Market, by Region, 2018-2030 (USD Million)
  • Table 4. Global Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5. Global Blood Screening Market, by Product, 2018-2030 (USD Million)
  • Table 6. North America Blood Screening Market, by Country, 2018-2030 (USD Million)
  • Table 7. North America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 8. North America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10. U.S. Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. Canada Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. Canada Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. Mexico Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14. Mexico Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Europe Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 17. Europe Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. UK Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19. UK Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 20. Germany Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21. Germany Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. France Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23. France Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 24. Italy Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25. Italy Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 26. Spain Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27. Spain Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Norway Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Norway Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 30. Denmark Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31. Denmark Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Sweden Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Sweden Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Japan Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38. Japan Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 39. China Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40. China Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 41. India Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42. India Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Australia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44. Australia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 45. South Korea Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46. South Korea Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Thailand Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48. Thailand Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 49. Latin America Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51. Latin America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Brazil Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Brazil Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Argentina Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55. Argentina Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 59. South Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60. South Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 63. UAE Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64. UAE Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Blood Screening Market, by Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Blood Screening Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot

Fig. 9 Product, and Technology Outlook (USD Million)

  • Fig. 10 Product, and Technology Outlook
  • Fig. 11 Competitive Landscape
  • Fig. 12 Blood Screening Market Dynamics
  • Fig. 13 Blood Screening Market: Porter's Five Forces Analysis
  • Fig. 14 Blood Screening Market: PESTLE Analysis
  • Fig. 15 Blood Screening Market: Technology Segment Dashboard
  • Fig. 16 Blood Screening Market: Technology Market Share Analysis, 2024 & 2030
  • Fig. 17 Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • Fig. 18 ELISA Market, 2018 - 2030 (USD Million)
  • Fig. 19 Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • Fig. 20 Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • Fig. 21 Western Blotting (WB) Market, 2018 - 2030 (USD Million)
  • Fig. 22 Blood Screening Market: Product Segment Dashboard
  • Fig. 23 Blood Screening Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 24 Reagent Market, 2018 - 2030 (USD Million)
  • Fig. 25 Instrument Market, 2018 - 2030 (USD Million)
  • Fig. 26 Blood Screening Market Revenue, by Region
  • Fig. 27 Regional marketplace: Key Takeaways
  • Fig. 28 Regional marketplace: Key Takeaways
  • Fig. 29 North America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Country Dynamics
  • Fig. 31 U.S. Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Country Dynamics
  • Fig. 33 Canada Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Country Dynamics
  • Fig. 35 Mexico Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Country Dynamics
  • Fig. 38 UK Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Country Dynamics
  • Fig. 40 Germany Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 41 France Country Dynamics
  • Fig. 42 France Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Country Dynamics
  • Fig. 44 Italy Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Country Dynamics
  • Fig. 46 Spain Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Country Dynamics
  • Fig. 48 Norway Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Country Dynamics
  • Fig. 50 Sweden Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark Country Dynamics
  • Fig. 52 Denmark Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Country Dynamics
  • Fig. 55 Japan Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 56 China Country Dynamics
  • Fig. 57 China Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 58 India Country Dynamics
  • Fig. 59 India Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Country Dynamics
  • Fig. 61 Australia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Country Dynamics
  • Fig. 63 South Korea Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Country Dynamics
  • Fig. 65 Thailand Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Country Dynamics
  • Fig. 68 Brazil Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina Country Dynamics
  • Fig. 70 Argentina Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa Country Dynamics
  • Fig. 73 South Africa Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia Country Dynamics
  • Fig. 75 Saudi Arabia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE Country Dynamics
  • Fig. 77 UAE Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait Key Country Dynamics
  • Fig. 79 Kuwait Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 80 Company Categorization
  • Fig. 81 Company Market Position Analysis
  • Fig. 82 Strategic Framework